Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 4/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | STAT3 | P40763 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | MAPT | P10636 | 6/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14303159 | 1.00 | TERT (0.53) | TERTCA12CA1CA2CA9 | |
| SCHEMBL14303166 | 0.84 | TERT (0.53) | TERTCA12CA1CA2CA9 | |
| SCHEMBL14309276 | 0.84 | TERT (0.56) | TERTCA12CA1CA2CA9 | |
| SCHEMBL14524634 | 0.84 | TERT (0.56) | TERTCA12CA1CA2CA9 | |
| SCHEMBL31257229 | 0.84 | TERT (0.53) | TERTCA12CA1CA2CA9 | |
| SCHEMBL14309284 | 0.84 | TERT (0.53) | TERTCA12CA1CA2CA9 | |
| SCHEMBL14650602 | 0.84 | TERT (0.42) | TERTCA12CA1CA2CA9 | |
| SCHEMBL29361586 | 0.84 | ALDH1A1 (0.67) | TERTCA12CA1CA2CA9 | |
| SCHEMBL14303136 | 0.84 | CASP3 (0.58) | TERTCA12CA1CA2CA9 | |
| SCHEMBL1630714 | 0.84 | ALDH1A1 (0.67) | TERTCA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12628491-B2 | Organic-inorganic adhesion layer and its use in perovskite solar cells and modules | Tandem PV (US) | 2026-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12628491-B2 | Organic-inorganic adhesion layer and its use in perovskite solar cells and modules | EPCAM, CDH1, L1CAM | TERT 1382/4885CA12 186/4885CA1 497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.